EXELIXIS, INC. (EXEL) capitalization

Current snapshot

Market Cap
$11.03B
251.4M shares × $43.88 · as of last filing 2026-04-03
Net Worth
$1.94B
Stockholders' equity · 2026-04-03
Enterprise Value
$10.42B
Market cap + debt − cash
Net Debt
-$607.7M
Debt $169.5M − Cash $777.2M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2026-01-02 $12.28B
FY'24 2025-01-03 $10.06B
FY'23 2023-12-29 $7.71B
FY'22 2022-12-30 $5.21B
FY'21 2021-12-31 $5.89B
FY'20 2021-01-01 $6.38B
FY'19 2020-01-03 $5.36B
FY'18 2018-12-28 $6.08B
FY'17 2017-12-29 $9.48B
FY'16 2016-12-31 $4.32B
FY'17 2016-12-30 $3.74B
FY'17 2016-01-01 $1.18B
FY'15 2015-12-31 $1.29B
FY'14 2014-12-31 $282.1M
FY'13 2013-12-31 $1.13B
FY'12 2012-12-31 $731.8M
FY'11 2011-12-31 $618.5M
FY'11 2010-12-31 $891.0M
FY'11 2009-12-31 $789.1M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-04-03 $11.73B
Q4'25 2026-01-02 $11.44B
Q3'25 2025-10-03 $11.17B
Q2'25 2025-07-04 $13.12B
Q1'25 2025-04-04 $9.96B
Q4'24 2025-01-03 $9.57B
Q3'24 2024-09-27 $7.57B
Q2'24 2024-06-28 $6.61B
Q1'24 2024-03-29 $7.25B
Q4'23 2023-12-29 $7.26B
Q3'23 2023-09-29 $6.98B
Q2'23 2023-06-30 $6.25B
Q1'23 2023-03-31 $6.33B
Q4'22 2022-12-30 $5.20B
Q3'22 2022-09-30 $5.10B
Q2'22 2022-07-01 $7.01B
Q1'22 2022-04-01 $7.40B
Q4'21 2021-12-31 $5.83B
Q3'21 2021-10-01 $6.94B
Q2'21 2021-07-02 $5.90B
Q1'21 2021-04-02 $7.43B
Q4'20 2021-01-01 $6.25B
Q3'20 2020-10-02 $7.23B
Q2'20 2020-07-03 $7.47B
Q1'20 2020-04-03 $5.22B
Q4'19 2020-01-03 $5.19B
Q3'19 2019-09-27 $5.68B
Q2'19 2019-06-28 $6.73B
Q1'19 2019-03-29 $7.49B
Q4'18 2018-12-28 $5.83B
Q3'18 2018-09-28 $5.53B
Q2'18 2018-06-29 $6.72B
Q1'18 2018-03-31 $6.57B
Q1'18 2018-03-30 $6.95B
Q1'18 2017-12-31 $9.00B
Q1'18 2017-12-30
Q4'17 2017-12-29 $9.00B
Q3'17 2017-09-30 $7.58B
Q3'18 2017-09-29 $7.58B
Q2'17 2017-06-30 $7.67B
Q1'17 2017-03-31 $6.71B
Q4'16 2016-12-31 $4.32B
Q4'17 2016-12-30 $4.32B
Q3'16 2016-09-30 $3.28B
Q2'16 2016-06-30 $1.79B
Q1'16 2016-03-31 $913.2M
Q4'15 2015-12-31 $1.29B
Q3'15 2015-09-30 $1.27B
Q2'15 2015-06-30 $738.4M
Q1'15 2015-03-31 $503.8M
Q4'14 2014-12-31 $282.1M
Q3'14 2014-09-30 $298.6M
Q2'14 2014-06-30 $661.4M
Q1'14 2014-03-31 $689.1M
Q4'13 2013-12-31 $1.13B
Q3'13 2013-09-30 $1.07B
Q2'13 2013-06-30 $835.8M
Q1'13 2013-03-31 $849.1M
Q4'12 2012-12-31 $839.5M
Q3'12 2012-09-30 $803.5M
Q2'12 2012-06-30 $822.8M
Q1'12 2012-03-31 $769.0M
Q4'11 2011-12-31 $642.6M
Q3'11 2011-09-30 $717.1M
Q2'11 2011-06-30 $1.16B
Q1'12 2011-03-31
Q4'11 2010-12-31 $897.2M
Q3'11 2010-09-30 $426.0M
Q2'11 2010-06-30
Q4'11 2009-12-31 $789.1M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (EXEL CIK 0000939767), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

XENE

XENON PHARMACEUTICALS INC.

ETON

Eton Pharmaceuticals, Inc.

OC

Owens Corning